Brainomix vs Lunit
Lunit sells to breast imaging programs and screening networks. Its newest decisions are INSIGHT MMG (v1.1.10, April 2026) and INSIGHT DBT (V1.2, March 2026), and it added Volpara breast density software when that acquisition closed in May 2024. INSIGHT CXR, which the vendor says highlights 11 thoracic abnormalities, has an openFDA record for triage (K211733). A radiology group reading chest films would look at it.
Brainomix scores NCCT, CTA, CTP and MRI for stroke, and the radiologists in an emergency department who read head scans are its buyer. It also sells e-Lung, CT lung quantification for fibrosis-type disease, cleared in May 2024 (K233875) and again in February 2025 (K242411).
Brainomix's modules are stroke and lung CT, and Lunit's are mammography, tomosynthesis and chest X-ray. A breast screening program and a stroke imaging team each have one clear choice here, and a chest section picks by the study it reads, X-ray with Lunit or CT with Brainomix.
Radiology · Reviewed November 2, 2026
Brainomix
by Brainomix Limited · founded 2012
FDA-cleared AI scoring and large vessel occlusion flagging for stroke CT, CTA, CTP and MRI, plus CT lung quantification.
Lunit
by Lunit · founded 2013
AI for chest X-ray, mammography and breast tomosynthesis, Volpara breast-density tools, and pathology biomarker software (SCOPE).
When to pick each one
Brainomix
- Stroke scoring on CT, CTA, CTP and MRI
- e-Lung CT quantification, K233875 and K242411
Lunit
- Mammography and DBT clearances, newest April 2026
- Volpara breast density software since the May 2024 acquisition
- INSIGHT CXR for chest X-ray triage, K211733
Score
Each row shows points earned of points available under the published rubric.
Brainomix
64of 100
Lunit
66of 100
| Dimension | Brainomix | Lunit | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 18.2 / 18.2 | 12.7 / 18.2 | +5.5 |
| RCT / meta-analysis / systematic review | 0 / 7.8 | 7.8 / 7.8 | -7.8 |
| Funding & adoption signal | 8.4 / 12 | 8.4 / 12 | 0 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 6 / 6 | 6 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Brainomix
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Lunit
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Contact form only. |
Evidence
Brainomix
FDA decisions
K260406 (opens in new tab)510(k)2026-06-12
Brainomix 360 Hyperdensity
K251983 (opens in new tab)510(k)2025-08-26
Brainomix 360 Triage Stroke
K242411 (opens in new tab)510(k)2025-02-19
Brainomix 360 e-Lung
K243294 (opens in new tab)510(k)2025-02-14
Brainomix 360 e-ASPECTS
K242123 (opens in new tab)510(k)2025-01-06
Brainomix 360 e-CTA
Show 8 more
K233875 (opens in new tab)510(k)2024-05-13
Brainomix 360 e-Lung
K232496 (opens in new tab)510(k)2023-11-21
Brainomix 360 Triage Stroke
K231837 (opens in new tab)510(k)2023-09-28
Brainomix 360 Triage LVO
K231656 (opens in new tab)510(k)2023-08-30
Brainomix 360 e-MRI
K231195 (opens in new tab)510(k)2023-07-27
Brainomix 360 Triage ICH
K223555 (opens in new tab)510(k)2023-06-01
Brainomix 360 e-CTP
K221564 (opens in new tab)510(k)2023-02-23
Brainomix 360 e-ASPECTS
K192692 (opens in new tab)510(k)2020-05-28
Brainomix 360 e-CTA
Peer-reviewed
5 PubMed records name Brainomix.
- Transforming Stroke Diagnosis with Artificial Intelligence: A Scoping Review of Brainomix e-Stroke, Aidoc, RapidAI, and Viz.ai. (opens in new tab)
- Real world clinical experience of using Brainomix e-CTA software in a medium size acute National Health Service Trust. (opens in new tab)
- Assessing the eligibility of Brainomix e-ASPECTS for acute stroke imaging. (opens in new tab)
Lunit
FDA decisions
K260320 (opens in new tab)510(k)2026-04-23
Lunit INSIGHT MMG (v1.1.10)
K253796 (opens in new tab)510(k)2026-03-26
Lunit INSIGHT DBT (V1.2)
K242652 (opens in new tab)510(k)2024-10-04
Lunit INSIGHT DBT v1.1
K231470 (opens in new tab)510(k)2023-11-06
Lunit INSIGHT DBT
K211678 (opens in new tab)510(k)2021-11-17
Lunit INSIGHT MMG
Show 3 more
K211733 (opens in new tab)510(k)2021-11-10
Lunit INSIGHT CXR Triage
K211279 (opens in new tab)510(k)2021-07-27
Volpara Imaging Software
K182310 (opens in new tab)510(k)2018-09-21
Volpara Imaging Software
Peer-reviewed
3 PubMed records name Lunit.
- Comparison of different Lunit INSIGHT CXR software versions when reading chest radiographs for tuberculosis. (opens in new tab)
- Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21). (opens in new tab)
- Long-term prognostic implications of AI-detected versus AI-undetected breast cancers on mammography: a propensity score-matched analysis. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Brainomix | Lunit |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | 2012 | 2013 |
| HQ | GB | KR |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.